Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Holders of 5% or more of ERAS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Erasca, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| City Hill, LLC | 13G/A | 10.40%37.0M shares | – | Feb 14, 20225 filings | Aug 14, 2026 | SEC |
| T. Rowe Price Investment Management, Inc. | 13G/A | 6.80%21.2M shares | +1.10 ppfrom 5.70% | Nov 14, 20244 filings | May 15, 2026 | SEC |
| Venrock Healthcare Capital Partners III, L.P. | 13G/A | 5.30%16.4M shares | – | May 31, 20242 filings | May 15, 2026 | SEC |
| Frazier Life Sciences Public Fund, L.P. | 13G/A | 5.30%15.0M shares | −2.70 ppfrom 8.00% | May 29, 20243 filings | Aug 14, 2025 | SEC |
| RTW Investments, LP | 13G | 5.20%16.2M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
41 Schedule 13D and 13G filings on Erasca, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:30 PM ET | City Hill, LLCand 2 others | 13G/A | 10.40%37.0M shares | – | Jun 30, 2026 | SEC |
| May 15, 20264:34 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 5.30%16.4M shares | – | Mar 31, 2026 | SEC |
| May 15, 20264:25 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G/A | 3.30%10.4M shares | −2.00 ppfrom 5.30%Below 5% | Mar 31, 2026 | SEC |
| May 15, 202610:06 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 6.80%21.2M shares | +1.10 ppfrom 5.70% | Mar 31, 2026 | SEC |
| May 15, 20268:20 AM ET | RTW Investments, LPand 1 other | 13G | 5.20%16.2M shares | New | Mar 31, 2026 | SEC |
| May 12, 20266:24 PM ET | Suvretta Capital Management, LLCand 2 others | 13G/A | 1.10%3.43M shares | −4.00 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 202610:28 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 5.70%16.1M shares | −1.50 ppfrom 7.20% | Dec 31, 2025 | SEC |
| Jan 14, 20264:30 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G | 5.30%15.2M shares | New | Jan 7, 2026 | SEC |
| Nov 14, 202512:59 PM ET | Logos Global Management LPand 2 others | 13G/A | 4.80%13.6M shares | −0.50 ppfrom 5.30%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20254:56 PM ET | Logos Global Management LPand 2 others | 13G | 5.30%15.1M shares | New | Jun 30, 2025 | SEC |
| Aug 14, 20251:10 PM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G/A | 5.30%15.0M shares | −2.70 ppfrom 8.00% | Jun 30, 2025 | SEC |
| Aug 14, 202512:12 PM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 7.20%20.3M shares | – | Jun 30, 2025 | SEC |
| Aug 13, 20258:14 PM ET | Suvretta Capital Management, LLCand 2 others | 13G | 5.10%14.5M shares | +0.70 ppfrom 4.40% | Jun 30, 2025 | SEC |
| May 15, 20259:44 AM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G/A | 8.00%22.6M shares | – | Mar 31, 2025 | SEC |
| Feb 13, 20258:09 PM ET | Suvretta Capital Management, LLCand 2 others | 13G/A | 4.40%12.3M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 20255:02 PM ET | Novartis Pharma AGand 1 other | 13G/A | 4.40%12.3M shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | T. Rowe Price Investment Management, Inc. | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | ARCH Venture Fund X, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 29, 2024 | City Hill, LLC | 13G/AOld format | – | – | – | SEC |
| Oct 24, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| May 31, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
| May 29, 2024 | Frazier Life Sciences Public Fund, L.P. | 13GOld format | – | New | – | SEC |
| May 28, 2024 | Suvretta Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | City Hill, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 30, 2024 | Cormorant Asset Management, LP | 13D/AOld format | – | – | – | SEC |
| Mar 10, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | City Hill, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | PFM Health Sciences, LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Dec 21, 2022 | Cormorant Asset Management, LP | 13D/AOld format | – | – | – | SEC |
| Dec 19, 2022 | Novartis Pharma AG | 13GOld format | – | New | – | SEC |
| Sep 6, 2022 | PFM Health Sciences, LP | 13GOld format | – | New | – | SEC |
| Mar 18, 2022 | Colt Ventures, Ltd. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | City Hill, LLC | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | ARCH Venture Fund X, L.P. | 13GOld format | – | New | – | SEC |
| Jan 10, 2022 | FMR LLC | 13GOld format | – | New | – | SEC |
| Aug 10, 2021 | Cormorant Asset Management, LP | 13D/AOld format | – | – | – | SEC |
| Jul 30, 2021 | Cormorant Asset Management, LP | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
43 notices from officers, directors and other affiliates planning to sell Erasca, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 202612:18 PM ET | Erasca FoundationFoundation | 8.33K | $122.4K | Oct 15, 202610b5-1 | Merrill Lynch | SEC |
| Sep 15, 20264:46 PM ET | Erasca FoundationFoundation | 8.33K | $133.1K | Sep 15, 202610b5-1 | Merrill Lynch | SEC |
| Aug 17, 20262:13 PM ET | Erasca FoundationFoundation | 8.33K | $152.4K | Aug 17, 202610b5-1 | Merrill Lynch | SEC |
| Jul 21, 20264:05 PM ET | Erasca FoundationFoundation | 8.33K | $157.6K | Jul 21, 202610b5-1 | Merrill Lynch | SEC |
| Jun 15, 20265:52 PM ET | Erasca FoundationFoundation | 8.33K | $117.5K | Jun 15, 202610b5-1 | Merrill Lynch | SEC |
| May 15, 20264:46 PM ET | Erasca FoundationFoundation | 8.33K | $84.5K | May 15, 202610b5-1 | Merrill Lynch | SEC |
| Apr 15, 20265:20 PM ETAmended | Erasca FoundationFoundation | 8.33K | $150.8K | Apr 15, 202610b5-1 | Merrill Lynch | SEC |
| Apr 1, 20262:19 PM ET | Ebun GarnerOfficer | 80.0K | $1.31M | Apr 1, 202610b5-1 | Merrill Lynch | SEC |
| Mar 16, 20262:38 PM ET | Erasca FoundationFoundation | 8.33K | $116.9K | Mar 16, 202610b5-1 | Merrill Lynch | SEC |
| Mar 4, 20265:38 PM ET | Shannon MorrisOfficer | 20.0K | $300.8K | Mar 4, 202610b5-1 | Merrill Lynch | SEC |
| Feb 17, 20262:27 PM ET | Erasca FoundationFoundation | 8.33K | $99.2K | Feb 17, 202610b5-1 | Merrill Lynch | SEC |
| Jan 15, 202610:43 AM ET | Erasca FoundationFoundation | 8.33K | $68.6K | Jan 15, 202610b5-1 | Merrill Lynch | SEC |
| Jan 7, 20263:58 PM ET | Ebun GarnerOfficer | 120.0K | $670.8K | Jan 7, 202610b5-1 | Merrill Lynch | SEC |
| Dec 15, 20258:11 PM ET | Erasca FoundationFoundation | 8.33K | $30.4K | Dec 15, 202510b5-1 | Merrill Lynch | SEC |
| Nov 17, 20254:27 PM ET | Erasca FoundationErasca Foundation | 8.33K | $21.6K | Nov 17, 202510b5-1 | Merrill Lynch | SEC |
| Oct 15, 20253:43 PM ET | Erasca FoundationErasca Foundation | 8.33K | $20.6K | Oct 15, 202510b5-1 | Merrill Lynch | SEC |
| Sep 15, 20254:21 PM ET | Erasca FoundationErasca Foundation | 8.33K | $12.9K | Sep 15, 202510b5-1 | Merrill Lynch | SEC |
| Aug 15, 20253:21 PM ET | Erasca FoundationErasca Foundation | 8.33K | $12.8K | Aug 15, 202510b5-1 | Merrill Lynch | SEC |
| Jul 15, 20253:56 PM ET | Erasca FoundationAffiliate | 8.33K | $11.8K | Jul 15, 202510b5-1 | Merrill Lynch | SEC |
| Jun 16, 20253:16 PM ET | Erasca FoundationAffiliate | 8.33K | $11.8K | Jun 16, 202510b5-1 | Merrill Lynch | SEC |
| May 15, 20254:15 PM ET | Erasca FoundationAffiliate | 8.33K | $9.90K | May 15, 202510b5-1 | Merrill Lynch | SEC |
| Apr 15, 20253:56 PM ET | Erasca FoundationAffiliate | 8.33K | $10.2K | Apr 15, 202510b5-1 | Merrill Lynch | SEC |
| Mar 17, 20254:41 PM ET | Erasca FoundationAffiliate | 8.33K | $11.7K | Mar 17, 202510b5-1 | Merrill Lynch | SEC |
| Feb 18, 20253:57 PM ET | Erasca FoundationAffiliate | 8.33K | $12.8K | Feb 18, 202510b5-1 | Merrill Lynch | SEC |
| Jan 15, 20252:19 PM ET | Erasca FoundationAffiliate | 8.33K | $16.2K | Jan 15, 202510b5-1 | Merrill Lynch | SEC |
Showing the latest 25. See the ERAS notices from the last 12 months